Experimental and Clinical Gastroenterology,
Journal Year:
2023,
Volume and Issue:
12, P. 4 - 68
Published: May 20, 2023
Summary
Post-
COVID
syndrome
refers
to
the
long-term
consequences
of
a
new
coronavirus
infection
COVID-19,
which
includes
set
symptoms
that
develop
or
persist
after
COVID-19.
Symptoms
gastrointestinal
disorders
in
post-
syndrome,
due
chronic
infl
ammation,
organ
damage,
prolonged
hospitalization,
social
isolation,
and
other
causes,
can
be
persistent
require
multidisciplinary
approach.
The
presented
clinical
practice
guidelines
consider
main
preventive
therapeutic
diagnostic
approaches
management
patients
with
gastroenterological
manifestations
postCOVID
syndrome.
Guidelines
were
approved
by
17th
National
Congress
Internal
Medicine
25th
Gastroenterological
Scientifi
c
Society
Russia.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 4, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
SARS-CoV-2
has
been
defined
as
the
greatest
global
health
and
socioeconomic
crisis
of
modern
times.
While
most
people
recover
after
being
infected
with
virus,
a
significant
proportion
them
continue
to
experience
issues
weeks,
months
even
years
acute
infection
SARS-CoV-2.
This
persistence
clinical
symptoms
in
individuals
for
at
least
three
onset
or
emergence
new
lasting
more
than
two
months,
without
any
other
explanation
alternative
diagnosis
have
named
long
COVID,
long-haul
post-COVID-19
conditions,
chronic
post-acute
sequelae
(PASC).
Long
COVID
characterized
constellation
disorders
that
vary
widely
their
manifestations.
Further,
mechanisms
underlying
are
not
fully
understood,
which
hamper
efficient
treatment
options.
review
describes
predictors
common
related
COVID's
effects
on
central
peripheral
nervous
system
organs
tissues.
Furthermore,
transcriptional
markers,
molecular
signaling
pathways
risk
factors
such
sex,
age,
pre-existing
condition,
hospitalization
during
phase
COVID-19,
vaccination,
lifestyle
presented.
Finally,
recommendations
patient
rehabilitation
management,
well
therapeutical
approaches
discussed.
Understanding
complexity
this
disease,
its
across
multiple
organ
systems
overlapping
pathologies
possible
paramount
developing
diagnostic
tools
treatments.
Canadian Journal of Cardiology,
Journal Year:
2023,
Volume and Issue:
39(6), P. 726 - 740
Published: Feb. 6, 2023
Statistics
Canada
estimated
that
approximately
1.4
million
Canadians
suffer
from
long
COVID.
Although
cardiovascular
changes
during
acute
SARS-CoV-2
infection
are
well
documented,
long-term
sequelae
less
understood.
In
this
review,
we
sought
to
characterize
adult
outcomes
in
the
months
after
COVID-19
illness.
our
search
identified
reports
of
including
cardiac
dysautonomia,
myocarditis,
ischemic
injuries,
and
ventricular
dysfunction.
Even
patients
without
overt
outcomes,
subclinical
have
been
observed.
Cardiovascular
can
stem
exacerbation
preexisting
conditions,
ongoing
inflammation,
or
as
a
result
damage
occurred
infection.
For
example,
myocardial
fibrosis
has
reported
hospital
admission
for
illness,
might
be
consequence
myocarditis
injury
disease.
turn,
contribute
further
dysrhythmias
heart
failure.
Severity
risk
factor
consequences,
however,
also
young,
healthy
individuals
who
had
asymptomatic
mild
evolving
evidence
suggests
previous
disease,
there
is
heterogeneity
existing
evidence,
some
studies
marred
by
measured
unmeasured
confounders.
Many
investigations
limited
relatively
short
follow-up.
Future
should
focus
on
longer
term
(beyond
1
year)
identifying
prevalence
different
populations
basis
COVID
disease
severity.
Pain Practice,
Journal Year:
2023,
Volume and Issue:
24(1), P. 120 - 159
Published: July 21, 2023
Abstract
Introduction
Individuals
recovering
from
acute
COVID‐19
episodes
may
continue
to
suffer
various
ongoing
symptoms,
collectively
referred
as
Long‐COVID.
Long‐term
pain
symptoms
are
amongst
the
most
common
and
clinically
significant
be
reported
for
this
post‐COVID‐19
syndrome.
Objectives
This
systematic
review
meta‐analysis
aimed
evaluate
proportions
of
persisting
experienced
by
individuals
past
phase
identify
their
associated
functional
consequences
inflammatory
correlates.
Methods
Two
online
databases
were
systematically
searched
inception
until
31
March
2022.
We
primary
research
articles
in
English,
which
evaluated
after
laboratory‐confirmed
resolution
specifically
on
and/or
outcomes.
Results
Of
611
identified
articles,
26
included,
used
data
extraction,
assessed
methodological
quality
risk
bias
two
independent
reviewers.
Pain
grouped
under
one
six
major
domains,
serving
our
co‐outcomes.
Proportional
meta‐analyses
pooled
logit‐transformed
values
single
performed
using
random‐effects‐restricted
maximum‐likelihood
model.
An
estimated
8%,
6%,
18%,
17%,
12%
continued
report
persistence
chest,
gastrointestinal,
musculoskeletal
joint,
muscle,
general
body,
nervous
system‐related
respectively,
up
year
COVID‐19.
Considerable
levels
heterogeneity
demonstrated
across
all
results.
Functional
quality‐of‐life
impairments
some
biomarker
elevations
with
long‐COVID
symptoms.
Conclusion
study's
findings
suggest
that
although
not
well
characterized,
being
non‐negligible
those
episodes,
thus
highlighting
importance
future
efforts
focus
aspect.
Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Feb. 9, 2023
Recent
numerous
epidemiology
and
clinical
association
studies
reported
that
ApoE
polymorphism
might
be
associated
with
the
risk
severity
of
coronavirus
disease
2019
(COVID-19),
yielded
inconsistent
results.
Severe
acute
respiratory
syndrome
2
(SARS-CoV-2)
infection
relies
on
its
spike
protein
binding
to
angiotensin-converting
enzyme
(ACE2)
receptor
expressed
host
cell
membranes.A
meta-analysis
was
conducted
clarify
between
COVID-19.
Multiple
interaction
assays
were
utilized
investigate
potential
molecular
link
SARS-CoV-2
primary
ACE2,
protein.
Immunoblotting
immunofluorescence
staining
methods
used
access
regulatory
effect
different
isoform
ACE2
expression.ApoE
gene
(ε4
carrier
genotypes
VS
non-ε4
genotypes)
is
increased
(P
=
0.0003,
OR
1.44,
95%
CI
1.18-1.76)
progression
<
0.00001,
1.85,
1.50-2.28)
interacts
both
but
did
not
show
isoform-dependent
effects.
ApoE4
significantly
downregulates
expression
in
vitro
vivo
subsequently
decreases
conversion
Ang
II
1-7.ApoE4
increases
infectivity
a
manner
may
depend
differential
interactions
or
ACE2.
Instead,
dysregulation
renin-angiotensin
system
(RAS)
provide
explanation
by
which
exacerbates
COVID-19
disease.
Frontiers in Neurology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 23, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
can
exacerbate
previous
headache
disorders
or
change
the
type
of
pain
experienced
from
headaches.
This
study
aimed
to
investigate
clinical
features
Long
COVID
headaches.This
was
a
cross-sectional,
descriptive,
and
analytical
observational
that
included
102
patients
(with
headache,
n
=
50;
without
52)
with
long
complaints.
The
Migraine
Disability
Assessment
Test
Visual
Analog
Pain
Scale
were
used
collect
participants'
data
according
standardized
protocol.The
in
this
who
reported
experiencing
headaches
before
COVID-19
had
longer
duration
phase
than
pre-long
(p
0.031),
exhibited
partial
improvement
symptoms
analgesics
0.045),
<1
year
0.030).
Patients
moderate
severe
disability
those
classified
as
having
highly
likely
develop
chronic
Hospital
admission
[odds
ratio
(OR)
3.0082;
95%
confidence
interval
(95%
CI):
1.10-8.26],
back
(OR
4.0017;
CI:
1.13-14.17),
insomnia
3.1339;
1.39-7.06),
paraesthesia
2.7600;
1.20-6.33)
associated
these
patients.Headache
is
disabling
condition
COVID-19,
exacerbating
conditions
prior
contracting
COVID-19.
Frontiers in Neurology,
Journal Year:
2024,
Volume and Issue:
15
Published: April 4, 2024
Corona
Virus
disease
2019
(COVID-19),
caused
by
the
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
has
presented
unprecedented
challenges
to
world.
Changes
after
COVID-19
have
had
a
significant
impact
on
patients
with
neurodegenerative
diseases.
This
study
aims
explore
mechanism
of
diseases
examining
main
pathways
central
nervous
system
infection
SARS-CoV-2.
Research
indicated
that
chronic
inflammation
and
abnormal
immune
response
are
primary
factors
leading
neuronal
damage
long-term
consequences
COVID-19.
In
some
patients,
concurrent
inflammatory
leads
increased
release
pro-inflammatory
cytokines,
which
may
significantly
prognosis.
Molecular
imaging
can
accurately
assess
severity
in
phase.
Furthermore,
use
FDG-PET
is
advocated
quantify
relationship
between
neuroinflammation
psychiatric
cognitive
symptoms
who
recovered
from
Future
development
should
focus
aggressive
post-infection
control
targeted
therapies
target
ACE2
receptors,
ERK1/2,
Ca
2+
.
Journal of Neurochemistry,
Journal Year:
2022,
Volume and Issue:
165(2), P. 115 - 130
Published: Dec. 2, 2022
Abstract
As
the
world
continues
to
experience
effects
of
SARS‐CoV‐2,
there
is
evidence
suggest
that
sequelae
viral
infection
(the
post‐COVID‐19
condition;
PCC)
at
both
an
individual
and
population
level
will
be
significant
long‐lasting.
The
history
pandemics
or
epidemics
in
last
100
years
caused
by
members
RNA
virus
family,
which
coronaviruses
are
a
member,
provides
ample
acute
neurological
effects.
However,
except
for
H1N1
influenza
pandemic
1918/1919
Spanish
flu)
with
its
associated
encephalitis
lethargica,
little
information
on
long‐term
sequelae.
COVID‐19
first
has
occurred
setting
aging
population,
especially
several
high‐income
countries.
Its
survivors
greatest
risk
developing
neurodegenerative
conditions
as
they
age,
rendering
current
unique
paradigm
not
previously
witnessed.
SARS‐CoV‐2
virus,
among
largest
viruses,
single‐stranded
encodes
29
proteins
include
spike
protein
contains
key
domains
required
ACE2
binding,
complex
array
nonstructural
(NSPs)
accessory
ensure
escape
from
innate
immune
response,
allowing
efficient
replication,
translation,
exocytosis
fully
functional
virion.
Increasingly,
these
also
recognized
potentially
contributing
biochemical
molecular
processes
underlying
neurodegeneration.
In
addition
directly
being
taken
up
brain
endothelium,
constituents
can
transported
neurons,
astrocytes,
microglia
extracellular
vesicles
accelerate
pathological
fibril
formation.
nucleocapsid
intrinsically
disordered
participate
liquid
condensate
formation,
including
heteropolymers
disease‐associated
RNA‐binding
such
TDP‐43,
FUS,
hnRNP1A.
mutate
under
pressure
exerted
highly
efficacious
vaccines,
it
evolving
into
greater
transmissibility
but
less
severity
compared
original
strain.
potential
lingering
impact
nervous
system
thus
represent
ongoing
legacy
even
global
health
challenge
than
infection.
image
Infectious Disease Reports,
Journal Year:
2023,
Volume and Issue:
15(6), P. 806 - 830
Published: Dec. 15, 2023
The
coronavirus
disease
2019
(COVID-19),
instigated
by
the
zoonotic
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
rapidly
transformed
from
an
outbreak
in
Wuhan,
China,
into
a
widespread
global
pandemic.
A
significant
post-infection
condition,
known
as
'long-
COVID-19'
(or
simply
COVID'),
emerges
substantial
subset
of
patients,
manifesting
with
constellation
over
200
reported
symptoms
that
span
multiple
organ
systems.
This
also
'post-acute
sequelae
SARS-CoV-2
infection'
(PASC),
presents
perplexing
clinical
picture
far-reaching
implications,
often
persisting
long
after
acute
phase.
While
initial
research
focused
on
immediate
pulmonary
impact
virus,
recognition
COVID-19
multiorgan
disruptor
has
unveiled
gamut
protracted
and
severe
health
issues.
review
summarizes
primary
effects
COVID
respiratory,
cardiovascular,
nervous
It
delves
mechanisms
underlying
these
impacts
underscores
critical
need
for
comprehensive
understanding
COVID's
pathogenesis.